Jonathan Glenn Sells 14,908 Shares of Consort Medical plc (LON:CSRT) Stock

Consort Medical plc (LON:CSRT) insider Jonathan Glenn sold 14,908 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of GBX 726 ($9.49), for a total transaction of £108,232.08 ($141,424.38).

CSRT stock opened at GBX 726 ($9.49) on Friday. The company has a market capitalization of $358.38 million and a PE ratio of 34.25. Consort Medical plc has a 12 month low of GBX 700 ($9.15) and a 12 month high of GBX 1,270 ($16.59). The firm’s 50-day moving average is GBX 788.74 and its 200 day moving average is GBX 873.36. The company has a debt-to-equity ratio of 46.56, a current ratio of 1.63 and a quick ratio of 1.04.

The business also recently declared a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 19th will be paid a GBX 13.80 ($0.18) dividend. This represents a yield of 1.53%. The ex-dividend date is Thursday, September 19th. This is an increase from Consort Medical’s previous dividend of $7.60. Consort Medical’s dividend payout ratio (DPR) is currently 1.32%.

CSRT has been the topic of several recent analyst reports. Royal Bank of Canada reduced their price target on shares of Consort Medical from GBX 1,320 ($17.25) to GBX 1,130 ($14.77) and set an “outperform” rating on the stock in a research note on Thursday, June 13th. Numis Securities downgraded shares of Consort Medical to a “hold” rating in a research note on Thursday, June 6th. Finally, Shore Capital reaffirmed a “buy” rating on shares of Consort Medical in a research note on Monday, July 15th.

About Consort Medical

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.

See Also: What is Green Investing?

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with's FREE daily email newsletter.